Consolidated Condensed Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 23, 2012
Net loss	$ (48,457)	$ (211,053)
Adjustments to reconcile net loss:
Depreciation and software amortization	16,673	24,759
Amortization of intangible assets	1,323	2,332
Deferred income taxes	9,853	15,021
Intraperiod tax allocation	(2,128)
Loss related to divestiture of discontinued operations (net of taxes)	30	142,591
Goodwill and other asset impairment (net of taxes)		6,472
Non-cash interest expense	7,036	6,773
Debt modification and extinguishment costs		35,415
Change in assets and liabilities:
Company owned life insurance (cash surrender value less policy loans including repayments)	8,965	(949)
Accounts receivable	584	5,439
Accounts payable, accrued expenses, and other liabilities	(23,034)	2,507
Retirement plan contributions	(3,803)	(9,097)
Other, net	5,135	(1,775)
Net cash (used) provided by operating activities	(27,823)	18,435
Investing activities:
Capital expenditures	(11,788)	(7,263)
Collateral refund (deposit) related to letters of credit	1,366	(10,271)
Net proceeds from sales of discontinued operations		139,902
Other, net	(68)	1,986
Net cash (used) provided by investing activities	(10,490)	124,354
Financing activities:
Increase in borrowings		13,000
Increase in related party borrowings	40,000	382,500
Repayment of borrowings		(377,298)
Repayment of related party borrowings	(10,000)	(126,963)
Debt issuance costs	(16,243)	(28,772)
Other, net	3,169	86
Net cash provided (used) by financing activities	16,926	(137,447)
Net (decrease) increase in cash and cash equivalents	(21,387)	5,342
Cash and cash equivalents at beginning of period	36,802	23,108
Cash and cash equivalents at end of period	15,415	28,450
Cash paid for interest	60,586	52,599
Non-cash financing activities:
Issuance of common stock warrants		$ (16,912)